Literature DB >> 12395214

Fasting plasma concentrations of selected flavonoids as markers of their ordinary dietary intake.

Jörg Radtke1, Jakob Linseisen, Günther Wolfram.   

Abstract

BACKGROUND: Dietary flavonoids, especially flavonols, are discussed as potentially preventive agents in the etiology of diseases such as coronary heart disease, stroke, and cancer. However, their consideration in epidemiologic studies is hampered by difficulties in exposure assessment. AIM OF THE STUDY: By comparison with dietary intake estimates, fasting plasma flavonoid concentrations should be evaluated as possible biomarkers of the ordinary dietary intake.
METHODS: 7-d dietary records were completed by 48 healthy female students. Flavonoid intake was estimated by means of available literature data on the flavonoid content of foods. Fasting plasma samples were taken at the end of the record period for flavonoid determination (HPLC).
RESULTS: The mean intake estimates (7-d period) of quercetin, kaempferol, naringenin, and hesperetin amounted to 17.9, 4.7, 12.1, and 17.4 mg/d, respectively; the corresponding mean plasma concentrations were 22.9, 10.7, 8.2, and 22.2 nmol/l. For all four flavonoids significant correlations between 7d-intake results and fasting plasma concentrations (r = 0.30-0.46, p < 0.05) existed. As expected from the known short elimination half-life of some plasma flavonoids, distinctly higher correlation coefficients were found for the relationship between intake estimates for the last day before blood sampling and the fasting plasma concentrations (r = 0.42-0.64; p < 0.01). The intraindividual variation in fasting plasma flavonoid concentrations during ad libitum intake was found to be rather high (mean coefficient of variation between 82 and 91 %; n = 4).
CONCLUSIONS: The flavonoid content in fasting plasma samples seems to be a suitable biomarker of short-term intake and a possible biomarker of the medium-term intake. Due to the high intraindividual variation the combined use of plasma flavonoid concentrations and dietary intake estimates may be the best choice in epidemiologic studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12395214     DOI: 10.1007/s00394-002-0377-z

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  13 in total

Review 1.  Potential role of flavonoids in the prevention of intestinal neoplasia: a review of their mode of action and their clinical perspectives.

Authors:  Harald P Hoensch; Wilhelm Kirch
Journal:  Int J Gastrointest Cancer       Date:  2005

2.  Emerging role of bioflavonoids in gastroenterology: Especially their effects on intestinal neoplasia.

Authors:  Harald P Hoensch; Reinhard Oertel
Journal:  World J Gastrointest Oncol       Date:  2011-05-15

3.  Induction of apoptosis by quercetin: different response of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells.

Authors:  Fabrizia Brisdelli; Cristina Coccia; Benedetta Cinque; Maria Grazia Cifone; Argante Bozzi
Journal:  Mol Cell Biochem       Date:  2006-09-13       Impact factor: 3.396

4.  Interactive effects of polyphenols, tocopherol and ascorbic acid on the Cu2+-mediated oxidative modification of human low density lipoproteins.

Authors:  Vera C Yeomans; Jakob Linseisen; Günther Wolfram
Journal:  Eur J Nutr       Date:  2005-04-15       Impact factor: 5.614

Review 5.  Biomarkers of dietary intake of flavonoids and phenolic acids for studying diet-cancer relationship in humans.

Authors:  Jakob Linseisen; Sabine Rohrmann
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

6.  Pretreatment serum xanthophyll concentrations as predictors of head and neck cancer recurrence and survival.

Authors:  Anna E Arthur; Emily L Bellile; Laura S Rozek; Karen E Peterson; Jianwei Ren; Ethan Harris; Christie Mueller; Shruti Jolly; Lisa A Peterson; Gregory T Wolf; Zora Djuric
Journal:  Head Neck       Date:  2015-11-28       Impact factor: 3.147

7.  Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.

Authors:  S Mosawy; D E Jackson; O L Woodman; M D Linden
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

8.  Perspective: Dietary Biomarkers of Intake and Exposure-Exploration with Omics Approaches.

Authors:  Padma Maruvada; Johanna W Lampe; David S Wishart; Dinesh Barupal; Deirdra N Chester; Dylan Dodd; Yannick Djoumbou-Feunang; Pieter C Dorrestein; Lars O Dragsted; John Draper; Linda C Duffy; Johanna T Dwyer; Nancy J Emenaker; Oliver Fiehn; Robert E Gerszten; Frank B Hu; Robert W Karp; David M Klurfeld; Maren R Laughlin; A Roger Little; Christopher J Lynch; Steven C Moore; Holly L Nicastro; Diane M O'Brien; José M Ordovás; Stavroula K Osganian; Mary Playdon; Ross Prentice; Daniel Raftery; Nichole Reisdorph; Helen M Roche; Sharon A Ross; Shengmin Sang; Augustin Scalbert; Pothur R Srinivas; Steven H Zeisel
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 11.567

Review 9.  Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits.

Authors:  Raul Zamora-Ros; Marina Touillaud; Joseph A Rothwell; Isabelle Romieu; Augustin Scalbert
Journal:  Am J Clin Nutr       Date:  2014-04-30       Impact factor: 7.045

10.  Kaempferol Induces Cell Cycle Arrest in HT-29 Human Colon Cancer Cells.

Authors:  Han Jin Cho; Jung Han Yoon Park
Journal:  J Cancer Prev       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.